SREAT Relapse vs. Steroid Withdrawal: Warning Signs
At a Glance
During a steroid taper, SREAT relapse may cause renewed confusion, severe memory or speech problems, balance changes, involuntary movements, or major mood and behavior changes, but withdrawal and adrenal insufficiency can look similar. A clinician must assess new symptoms.
Tapering off corticosteroids after being treated for Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT, also known as Hashimoto’s encephalopathy) can be a highly anxious time. Relapses have been reported during dose reductions and after stopping medications, though their exact frequency and timing are uncertain [1][2].
Because tapering steroids also causes a predictable withdrawal process, it can be very difficult to know if your body is just adjusting to lower medication levels, if your adrenal glands are struggling, or if SREAT is returning. It is crucial to understand that you cannot reliably diagnose the cause of your symptoms at home. While withdrawal often causes physical fatigue and SREAT often causes neurological issues, these conditions overlap significantly. For example, a relapse might begin with generalized fatigue, while withdrawal or adrenal insufficiency can cause confusion, sleep disturbances, and mood changes [3][4][5]. Always seek a clinician’s assessment for new or worsening symptoms rather than trying to diagnose yourself based on how a symptom feels.
🚨 EMERGENCY RED FLAGS
Do not wait for a doctor’s appointment, a scheduled test, or a callback if you experience any of the following. Call emergency services immediately. These can be signs of a life-threatening adrenal crisis, a severe SREAT relapse, an infection, or another medical emergency like a stroke:
- Neurological emergencies: First or prolonged seizures, sudden inability to speak or walk, markedly reduced consciousness, coma, or rapidly worsening confusion [3][6].
- Psychiatric emergencies: New severe psychosis, delusions, or hallucinations [3].
- Adrenal Crisis signs: Collapse, fainting (syncope), severe dizziness upon standing (hypotension), persistent vomiting, inability to keep steroid medication down, or severe physical weakness [7][5].
Potential Signs of a SREAT Relapse
A SREAT relapse means the encephalopathy (brain dysfunction) has returned. During a steroid reduction, relapses often—but not always—mimic the exact symptoms you experienced during your initial episode [2][1]. Features that raise clinical concern for a relapse include:
- Cognitive and Neurological Deficits: Severe memory impairment, confusion, clumsiness or loss of balance (gait disturbance), speech problems, and involuntary movements [3][2].
- Psychiatric Changes: Profound mood swings, major behavioral changes, or persecutory delusions (beliefs that someone is trying to harm you) [3]. (Note: Corticosteroids themselves, as well as adrenal issues, can also cause significant psychiatric side effects, meaning any severe mood or behavioral change requires formal medical evaluation).
Glucocorticoid Withdrawal and Adrenal Insufficiency
When you take high doses of steroids for a prolonged period, your body’s adrenal glands suppress their natural production of cortisol. As you taper, it takes time for this system to recover [8].
- Glucocorticoid Withdrawal Syndrome: This common adjustment period often causes profound generalized fatigue, muscle aches (myalgias), joint pains (arthralgias), sleep disturbances, and mild to moderate mood changes [4][9].
- Adrenal Insufficiency: If your adrenal glands do not wake up adequately, you may develop adrenal insufficiency. This can happen gradually, causing increasing fatigue, nausea, and weakness. If severe, it can culminate in a sudden, life-threatening adrenal crisis [7][5].
Why Diagnosis Requires Your Doctor
There is no single confirmatory test for a SREAT relapse, and your care team will need to evaluate you to rule out other causes like infections, medication side effects, or metabolic imbalances [10].
- Scans and tests can be normal: Having a normal brain MRI or normal routine cerebrospinal fluid (CSF) results does not exclude a relapse [2]. An EEG (brain wave test) is often abnormal in SREAT (typically showing generalized slowing), but this finding is nonspecific and cannot definitively prove a relapse on its own [3].
- Antibodies are not proof of relapse: High thyroid antibodies are common in autoimmune thyroid disease but do not measure current brain inflammation. In one study of patients referred for suspected Hashimoto’s encephalopathy who had elevated thyroid antibodies, 73% were ultimately found to have a completely different, non-immune diagnosis [11].
- Adrenal testing: Your doctor may use tests like a morning cortisol draw or an ACTH stimulation test to check if your adrenal glands are recovering [12].
Your Action Plan
- Follow your taper strictly: Do not speed up, stop, or change your long-term steroid taper without your prescriber’s direction.
- Use sick-day rules if prescribed: If your doctor has given you a specific “sick-day plan” (instructions to take extra steroids during a fever, major illness, or vomiting) or an emergency hydrocortisone injection kit, follow those instructions and seek immediate medical care.
- Track your symptoms: Keep a daily symptom diary noting your current dose, the timing of symptoms relative to dose reductions, sleep patterns, and any physical or neurological changes. This gives your care team objective data to review.
Common questions in this guide
What are possible signs of a SREAT relapse during a steroid taper?
How can I tell a SREAT relapse from steroid withdrawal?
When should I call emergency services during a steroid taper?
Can a normal MRI or high thyroid antibodies rule out a SREAT relapse?
What tests might show whether my symptoms are from adrenal suppression?
Should I change my steroid dose if symptoms return during the taper?
Related questions
Show more
Get notified when new evidence is published on Steroid-responsive encephalopathy associated with autoimmune thyroiditis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
A young man with convulsive laughter.
Toft A, Meisingset TW, Sæther SG
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2020; (140(8)) doi:10.4045/tidsskr.19.0612.
PMID: 32463185 - 2
[A suspected case of Hashimoto encephalopathy with frequent relapses despite multiple courses of immunotherapy].
Harada S, Inatomi Y, Nakajima M, Yonehara T
Rinsho shinkeigaku = Clinical neurology 2020; (60(3)):200-205 doi:10.5692/clinicalneurol.cn-001361.
PMID: 32101843 - 3
Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature.
Laurent C, Capron J, Quillerou B, et al.
Autoimmunity reviews 2016; (15(12)):1129-1133 doi:10.1016/j.autrev.2016.09.008.
PMID: 27639840 - 4
Potential mechanisms of the glucocorticoid withdrawal syndrome.
Snyder CN, Frontera ED, Meng J, et al.
European journal of endocrinology 2026; (194(4)):R67-R81 doi:10.1093/ejendo/lvag062.
PMID: 41988948 - 5
Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency.
Borresen SW, Klose M, Glintborg D, et al.
The Journal of clinical endocrinology and metabolism 2022; (107(7)):2065-2076 doi:10.1210/clinem/dgac151.
PMID: 35302603 - 6
Super refractory status epilepticus as an atypical presentation of Hashimoto's encephalopathy.
Chaponan-Lavalle A, Alave J, Fernandez F, et al.
Epilepsy & behavior reports 2026; (34()):100862 doi:10.1016/j.ebr.2026.100862.
PMID: 41908686 - 7
Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis.
Laugesen K, Petersen I, Sørensen HT, Jørgensen JOL
PloS one 2019; (14(2)):e0212259 doi:10.1371/journal.pone.0212259.
PMID: 30779776 - 8
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.
Beuschlein F, Else T, Bancos I, et al.
European journal of endocrinology 2024; (190(5)):G25-G51 doi:10.1093/ejendo/lvae029.
PMID: 38714321 - 9
Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study.
Zhang CD, Li D, Singh S, et al.
European journal of endocrinology 2023; (188(7)):592-602 doi:10.1093/ejendo/lvad073.
PMID: 37395115 - 10
Hashimoto's Encephalopathy: Case Series and Literature Review.
Chaudhuri J, Mukherjee A, Chakravarty A
Current neurology and neuroscience reports 2023; (23(4)):167-175 doi:10.1007/s11910-023-01255-5.
PMID: 36853554 - 11
Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis.
Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al.
Brain communications 2021; (3(2)):fcaa233 doi:10.1093/braincomms/fcaa233.
PMID: 34061124 - 12
Morning serum cortisol as a predictor of synacthen stimulation test outcomes during corticosteroid withdrawal: a comparative analysis of high-dose and low-dose protocols.
Saiegh L, Dakwar B, Jovanovic K, et al.
Frontiers in endocrinology 2025; (16()):1655146 doi:10.3389/fendo.2025.1655146.
PMID: 41122714
This page is for informational purposes only and does not constitute medical advice or diagnose SREAT relapse, steroid withdrawal, or adrenal insufficiency. Follow your prescriber's taper plan and seek emergency care for severe neurological symptoms, collapse, persistent vomiting, or inability to keep steroids down.